These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
136 related articles for article (PubMed ID: 8385260)
21. Formulation of radiographically detectable gastrointestinal contrast agents for magnetic resonance imaging: effects of a barium sulfate additive on MR contrast agent effectiveness. Rubin DL; Muller HH; Young SW Magn Reson Med; 1992 Jan; 23(1):154-65. PubMed ID: 1734177 [TBL] [Abstract][Full Text] [Related]
22. Gadolinium(III) complexes of mono- and diethyl esters of monophosphonic acid analogue of DOTA as potential MRI contrast agents: solution structures and relaxometric studies. Lebdusková P; Hermann P; Helm L; Tóth E; Kotek J; Binnemans K; Rudovský J; Lukes I; Merbach AE Dalton Trans; 2007 Jan; (4):493-501. PubMed ID: 17213936 [TBL] [Abstract][Full Text] [Related]
23. Comparison of gadolinium-DTPA and polylysine-gadolinium-DTPA--enhanced magnetic resonance imaging of hepatocarcinoma in the rat. Grandin C; Van Beers BE; Demeure R; Goudemant JF; Mottet I; Pringot J Invest Radiol; 1995 Oct; 30(10):572-81. PubMed ID: 8557496 [TBL] [Abstract][Full Text] [Related]
24. Intraindividual in vivo comparison of gadolinium contrast agents for pharmacokinetic analysis using dynamic contrast enhanced magnetic resonance imaging. Liang J; Sammet S; Yang X; Jia G; Takayama Y; Knopp MV Invest Radiol; 2010 May; 45(5):233-44. PubMed ID: 20351653 [TBL] [Abstract][Full Text] [Related]
25. Mannan-coated liposome delivery of gadolinium-diethylenetriaminepentaacetic acid, a contrast agent for use in magnetic resonance imaging. Kunimasa J; Inui K; Hori R; Kawamura Y; Endo K Chem Pharm Bull (Tokyo); 1992 Sep; 40(9):2565-7. PubMed ID: 1446380 [TBL] [Abstract][Full Text] [Related]
26. Synthesis and evaluation of novel macrocyclic and acyclic ligands as contrast enhancement agents for magnetic resonance imaging. Chong HS; Garmestani K; Bryant LH; Milenic DE; Overstreet T; Birch N; Le T; Brady ED; Brechbiel MW J Med Chem; 2006 Mar; 49(6):2055-62. PubMed ID: 16539394 [TBL] [Abstract][Full Text] [Related]
27. Use of Gd-DTPA and fast gradient-echo and spin-echo MR imaging to demonstrate renal function in the rabbit. Carvlin MJ; Arger PH; Kundel HL; Axel L; Dougherty L; Kassab EA; Moore B Radiology; 1989 Mar; 170(3 Pt 1):705-11. PubMed ID: 2916024 [TBL] [Abstract][Full Text] [Related]
28. Chelating DTPA amphiphiles: ion-tunable self-assembly structures and gadolinium complexes. Moghaddam MJ; de Campo L; Kirby N; Drummond CJ Phys Chem Chem Phys; 2012 Oct; 14(37):12854-62. PubMed ID: 22890045 [TBL] [Abstract][Full Text] [Related]
29. Flow-injection EPR investigation on OH radical scavenging activity of Gd(III) containing MRI contrast media. Mori Y; Watanabe R; Sakamoto S; Endo N; Nakano S; Kanaori K; Takashima H; Ohkawa M; Tajima K J Med; 2004; 35(1-6):49-61. PubMed ID: 18084864 [TBL] [Abstract][Full Text] [Related]
30. [Oral contrast medium for magnetic resonance tomography of the abdomen. II. Phase I clinical testing of gadolinium-DTPA]. Kornmesser W; Laniado M; Hamm B; Clauss W; Weinmann HJ; Schulz E; Wolf KJ; Felix R Rofo; 1987 Nov; 147(5):550-6. PubMed ID: 2825293 [TBL] [Abstract][Full Text] [Related]
31. Concentration of gadolinium-diethylene triamine pentaacetic acid in human kidney--study on proper time for dynamic magnetic resonance imaging of the human kidney on low and high magnetic fields. Takeda M; Katayama Y; Tsutsui T; Komeyama T; Mizusawa T; Tanikawa T; Sato S Tohoku J Exp Med; 1993 Oct; 171(2):119-28. PubMed ID: 8128480 [TBL] [Abstract][Full Text] [Related]
32. Simple method for quantification of gadolinium magnetic resonance imaging contrast agents using ESR spectroscopy. Takeshita K; Kinoshita S; Okazaki S Chem Pharm Bull (Tokyo); 2012; 60(1):31-6. PubMed ID: 22223372 [TBL] [Abstract][Full Text] [Related]
33. Gd-DTPA in MR of spinal lesions. Valk J AJR Am J Roentgenol; 1988 May; 150(5):1163-8. PubMed ID: 3258721 [TBL] [Abstract][Full Text] [Related]
34. A high-frequency EPR study of frozen solutions of Gd(III) complexes: straightforward determination of the zero-field splitting parameters and simulation of the NMRD profiles. Benmelouka M; Van Tol J; Borel A; Port M; Helm L; Brunel LC; Merbach AE J Am Chem Soc; 2006 Jun; 128(24):7807-16. PubMed ID: 16771494 [TBL] [Abstract][Full Text] [Related]
35. The value of paramagnetic contrast agent gadolinium-DTPA in the diagnosis of pituitary adenomas. Nakamura T; Schörner W; Bittner RC; Felix R Neuroradiology; 1988; 30(6):481-6. PubMed ID: 3226534 [TBL] [Abstract][Full Text] [Related]
36. AUR Memorial Award 1991. Immunogenicity of gadolinium-based contrast agents for magnetic resonance imaging. Induction and characterization of antibodies in animals. Baxter AB; Melnikoff S; Stites DP; Brasch RC Invest Radiol; 1991 Dec; 26(12):1035-40. PubMed ID: 1722486 [TBL] [Abstract][Full Text] [Related]
37. Dissociation of gadolinium chelates in mice: relationship to chemical characteristics. Wedeking P; Kumar K; Tweedle MF Magn Reson Imaging; 1992; 10(4):641-8. PubMed ID: 1501535 [TBL] [Abstract][Full Text] [Related]
38. Structure-activity relationship of macrocyclic and linear gadolinium chelates: investigation of transmetallation effect on the zinc-dependent metallopeptidase angiotensin-converting enzyme. Corot C; Idee JM; Hentsch AM; Santus R; Mallet C; Goulas V; Bonnemain B; Meyer D J Magn Reson Imaging; 1998; 8(3):695-702. PubMed ID: 9626889 [TBL] [Abstract][Full Text] [Related]
39. Interactions of paramagnetic contrast agents and the spin echo pulse sequence. Joseph PM Invest Radiol; 1989 Jun; 24(6):508-9. PubMed ID: 2562496 [No Abstract] [Full Text] [Related]
40. Paramagnetic agents as tracers in magnetic resonance imaging. Extrapolations from Gd-DTPA to everything. Koenig SH Acta Radiol Suppl; 1990; 374():17-23. PubMed ID: 1966965 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]